ConCallIQ
Go Pro
AETHER Diversified 15 Jan 2026

Aether Industries Limited — Q3 FY26

Aether Industries delivered a strong Q3 FY26 with consolidated revenue of ₹317.1 crore (+44% YoY) and EBITDA of ₹108.3 crore (+75% YoY), driven by robust volume growth in large-...

bullish high
Compare with...
Revenue ₹317 Cr +44%
EBITDA ₹108 Cr +75%
PAT ₹65 Cr +49%
EBITDA Margin 34% +600bps
Duration 62 min
Read Time 1 min read

✓ Verified against BSE filing

Questions answered85%
Questions audited10
Evaded / deflected1
Numbers vs filingContradicted
Claim Ledger

Did management answer the analysts?

Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.

Evasive Medium priority

How does Aether treat talent retention as a core priority?

Asked by Sajel Kapoor, antifracy thinking

Management listed general retention efforts but avoided naming any hard tradeoffs made.

no specific tradeoffs mentionedgeneric HR platitudes
Read the exchange
Question
How does Ather treat talent retention as a core priority and what hard tradeoffs has management consciously made in favor of employee continuity?
Dr. Raman (management)
We spend a lot of time at the management level focusing on this issue. We have attractive ESOPs, packages, incentives across the company. We are very careful in selection of candidates. Surat is a nice city to live in.
Answered Medium priority

How does Aether's culture show up during scale-up experiment failures?

Asked by Sajel Kapoor, antifracy thinking

Management gave specific examples of leadership involvement and safety culture.

Read the exchange
Question
When scaleup experiments fail, how does Aether's culture show up on the ground? What behaviors signal psychological safety and trust?
Dr. Raman (management)
We lead from the top. Our promoter family is a mix of techno-commercial excellence. We have about 50 projects going on in R&D today, all directly led by myself. We have a culture of stop work at all levels.
Answered High priority

Strategy for CM: acquire new customers or gain pocket share?

Asked by Pikshit Gujarati, Nishad

Management clearly stated both strategies and provided supporting details.

Read the exchange
Question
What will be your strategy, will you acquire new CM customers over time or gain pocket share of existing customers?
Dr. Raman (management)
The answer is both. We work extremely hard in curating relationships with innovators. We want the next 10 products in their pipeline. We are continuously looking for new customers, exhibiting in about 10 shows worldwide.
Answered Medium priority

Time to convert a customer from CRAMS to CM?

Asked by Pikshit Gujarati, Nishad

Management gave a range and an average, directly answering the question.

Read the exchange
Question
How much time does it take to convert a customer from CRAMS to CM?
Dr. Raman (management)
It really depends. Examples from 6 months to 6 years. On average, between one to two years.
Answered High priority

Future revenue contribution from CRAMS/CM vs LSM?

Asked by Pikshit Gujarati, Nishad

Management provided a clear target percentage split.

Read the exchange
Question
Down the line two-three years, what contribution will be from this segment of total revenue?
Dr. Raman (management)
What we're targeting is basically 70% of our revenue coming from CRAMS and CM and 30% coming from large scale manufacturing.
Declined Low priority

Name of the new European customer in material science?

Asked by Manishadani, 361 Capital

Management explicitly declined to name the customer.

refused to disclose name
Read the exchange
Question
Is the customer name because they are also into material science?
Dr. Raman (management)
We do not name our customers. It's a customer from Europe in the material science sector. We'll not comment anything further.
Answered High priority

Entry barriers and pricing pressure in non-pharma non-agro CM?

Asked by Deng, Tiger Assets

Management provided specific reasons for barriers and lack of pricing pressure.

Read the exchange
Question
How high are entry barriers for global chemical players? What makes customers prefer outsourcing to you rather than backward integrating? How protected from pricing pressure?
Dr. Raman (management)
In the west it's increasingly impossible to manufacture anymore. Pricing has increased significantly in the west. These companies don't typically shop around once they establish strategic partnerships. There is no pricing pressure.
Answered High priority

Contract renewal cycle and pricing mechanism?

Asked by Deng, Tiger Assets

Management gave contract duration and pricing mechanism clearly.

Read the exchange
Question
How often are contracts renewed and are they done at fixed prices or linked to spot or raw material prices?
Dr. Raman (management)
Contracts are usually for five to ten year minimum, then auto-renewed. Pricings are negotiated every year based on open costing sheet platform.
Partial answer Medium priority

Clarity on other CM contracts and Converge Polyol status?

Asked by Kumar Somia, Ambit Capital

Management gave qualitative update but no quantitative details on other contracts.

no specific revenue numbersvague on legacy contracts
Read the exchange
Question
Could you give some more clarity on how the other contracts are panning out? Where are we on Converge Polyol and how is the base legacy contract business doing?
Dr. Raman (management)
Converge Polyol is picking up very well. A lot of new customers are sampling and have given small quantity orders. One product had a cyclical trend but will turn up good this quarter.
Evasive Low priority

Key products driving LSM improvement?

Asked by Kumar Somia, Ambit Capital

Management declined to name products on the call.

refused to name productsoffered offline discussion
Read the exchange
Question
What would be the key product that would be driving that?
Dr. Raman (management)
We have several key products on this but we would not like to discuss the products but we can discuss it offline.
Answered High priority

Demand trend in pharma and agro business?

Asked by Kumar Somia, Ambit Capital

Management provided specific volume growth percentages.

Read the exchange
Question
How is the demand trend right now in pharma API intermediates?
Dr. Raman (management)
Volumes have increased quarter on quarter 10%, year on year 25% for us. We are seeing good demand. Prices have bottomed out.
Answered High priority

Sustainable EBITDA margin guidance?

Asked by Kumar Somia, Ambit Capital

Management gave a specific margin range and explained the one-time item.

Read the exchange
Question
Will it be fair to assume sustainable EBITDA margin run rate of roughly 34-35%?
Dr. Raman (management)
We would like to still be conservative and always be around 29 to 30%, not more than that. There's a one-time FLOP claim that has increased margins.
Quantitative claims vs filed numbers
ClaimManagement saidFilingVerdict
Volumes increased 10% QoQ, 25% YoY for LSM 25% 44% Understated vs filing
CRAMS EBITDA margin 60-65% 62.5% 34% Overstated vs filing
CM EBITDA margin 27-30% 28.5% 34% Understated vs filing
LSM EBITDA margin 21-23% 22% 34% Understated vs filing
Baker Hughes revenue grew 20% QoQ 20% 44% Understated vs filing

Filed figures sourced from Screener.in. Claims within a small tolerance of the filing are marked “matches filing”.